Results 101 to 110 of about 7,677 (149)

Plain Language Summary of Publication: Design of the Phase 3 AZALEA Trial of Nipocalimab in Severe Hemolytic Disease of the Fetus and Newborn. [PDF]

Am J Perinatol
Komatsu Y, Olusajo V, Ling LE, Saeed-Khawaja S, Tjoa ML, Vaikunthanathan T, Mirza A, Moise KJ.   +7 more
europepmc   +1 more source

<i>Rhododendron jiucaipingensis</i> (Ericaceae), a new species from Guizhou, China. [PDF]

PhytoKeys
Hu HF, Xu J, An MT, Yu JH, Lu X.
europepmc   +1 more source

Lipid-gated vesicular trafficking directs HSPA1A to the plasma membrane through the endo-lysosomal network. [PDF]

Cell Stress Chaperones
Low J, Cuaresma AB, Martin CK, Badolian A, AlSebaye M, Stahelin RV, Nikolaidis N.   +6 more
europepmc   +1 more source

Scrofuloderma and Miliary Tuberculosis in a 27-Year-Old Nurse. [PDF]

Cureus
Lugo Rincón-Gallardo FJ, Rodríguez Trujillo ND, Altamirano De La Cruz AG, Castillo Gómez AP, Arrazola KS.   +4 more
europepmc   +1 more source

Safety of Factor XI Inhibition With Abelacimab in Atrial Fibrillation by Kidney Function: A Prespecified Analysis of the AZALEA-TIMI 71 Randomized Clinical Trial.

JAMA Cardiol
Patel SM, Giugliano RP, Morrow DA, Goodrich EL, Murphy SA, Hug B, Parkar S, Chen SA, Goodman SG, Joung B, Kiss RG, Wojakowski W, Weitz JI, Bloomfield D, Sabatine MS, Ruff CT.   +15 more
europepmc   +1 more source

Long-Acting Factor XI Inhibition and Periprocedural Bleeding: An Analysis From AZALEA-TIMI 71. [PDF]

J Am Coll Cardiol
Patel SM, Giugliano RP, Morrow DA, Parkar S, Shapiro H, Hug B, Kuder JF, Goodrich EL, Chen SA, Goodman SG, Joung B, Kiss RG, Wojakowski W, Weitz JI, Murphy SA, Wiviott SD, Bloomfield D, Sabatine MS, Ruff CT.   +18 more
europepmc   +1 more source

Post-Quantum Revocable Linkable Ring Signature Scheme Based on SPHINCS+ for V2G Scenarios. [PDF]

Sensors (Basel)
Liu S, Du YN, Wang XA, Hu X, Su HE.
europepmc   +1 more source

Factor XI Inhibition for Atrial Fibrillation: Where Do We Stand? [PDF]

Circulation
Patel SM, Giugliano RP, Ruff CT.
europepmc   +1 more source

Factor XI Inhibitors in Atrial Fibrillation: Insights and Implications from Recent Trials. [PDF]

Adv Ther
Falama RB, Matsumoto LR, Piatski ME, Seifer L, Malhotra A, McCarty OJT, Shatzel JJ.   +6 more
europepmc   +1 more source

Reducing Plasma Factor XI Concentration With siRNA Technology. [PDF]

JACC Basic Transl Sci
Gailani D.
europepmc   +1 more source